Announcement on the proposed 100% strategic acquisition
of Renhe Medical Group Co., Ltd. by Intuitive Surgical, Inc. (NASDAQ: ISRG)

The Board of Directors of Renhe Medical Group Co., Ltd. (hereinafter referred to as “Renhe Medical”) hereby announces to global partners, investment institutions, medical industry partners, and the public:

Following long-term strategic communication and multiple rounds of commercial discussions, Intuitive Surgical, Inc. (NASDAQ: ISRG), a global leader in robotic-assisted minimally invasive surgical medical technology, has reached a preliminary cooperation intention with Renhe Medical regarding a comprehensive strategic acquisition.

According to the parties’ plan, Intuitive Surgical intends to conduct a 100% equity strategic acquisition of Renhe Medical through an equity acquisition method (Wholly Owned Acquisition).

After completion of this transaction, the equity structure will be as follows:

1. Global medical robotics technology collaboration

Leveraging Intuitive Surgical’s technological strengths in robotic-assisted surgical systems, AI-assisted healthcare, and global medical technology, together with Renhe Medical’s presence in regional medical resources, smart healthcare, and industry ecosystems, the parties will jointly advance the development of next-generation intelligent medical technology.

2. Building an AI medical ecosystem

The parties plan to deepen cooperation in the following areas:

• AI-assisted diagnostic systems;
• Smart hospital solutions;
• Medical big data analytics platforms;
• Digital medical service systems;
• Global medical technology innovation cooperation.

3. Deepening the Asia-Pacific strategic layout

This strategic acquisition will further strengthen the parties’ market collaboration capabilities in the Asia-Pacific region and accelerate the globalization of medical robotics, smart healthcare, and digital medical businesses.

(1) Acquisition percentage

After completion of this transaction:

• Intuitive Surgical will hold 100% of Renhe Medical’s equity;
• Renhe Medical will become a wholly owned subsidiary within Intuitive Surgical’s global medical industry system;
• The original shareholders will complete the transfer of all equity.

(2) Transaction method

The transaction consideration is proposed to adopt internationally accepted capital market methods, including but not limited to:

• Cash consideration;
• Stock consideration;
• A combination of cash and stock;
• Other capital arrangements confirmed by both parties.

(3) Enterprise valuation and transaction price

In accordance with international M&A practices, the parties will engage international third-party professional institutions to conduct:

• Financial Due Diligence;
• Legal Due Diligence;
• Commercial Due Diligence;
• Business Valuation.

The final transaction price will be confirmed by both parties based on the independent valuation report, asset value, core technologies, intellectual property, market size, and future development potential.

This strategic acquisition is expected to proceed according to the following process:

After completion of the transaction, Renhe Medical will rely on Intuitive Surgical’s global medical technology platform to comprehensively upgrade in the following areas:

• Clinical applications of medical robotics;
• AI intelligent diagnosis and treatment technologies;
• Smart hospital construction;
• International medical cooperation networks;
• Asia-Pacific medical technology industry layout.

Through the integration of capital, technology, talent, and global market resources, the parties will jointly build an internationally leading next-generation intelligent medical ecosystem.

The strategic acquisition described in this announcement remains subject to completion of matters including but not limited to:

• Board and relevant internal approval procedures of both parties;
• Signing of final legal documents;
• Necessary government and regulatory approvals;
• Other transaction closing conditions.

There is uncertainty as to whether this transaction will ultimately be completed and when it will be completed.

Relevant information shall be subject to documents formally signed and legally disclosed by both parties in the future.

Board of Directors of Renhe Medical Group Co., Ltd.

Publication date: June 12, 2026